unknown
Stage
2014
Founded
1
Investors
About
Azura Ophthalmics develops first-in-class ophthalmic keratolytic therapeutics focusing on treating eye diseases related to meibomian gland dysfunction and dry eye disease by targeting the root causes of ocular surface disorders.
Explore Azura Ophthalmics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.